ParagonCare lifts pharmacy sales

Healthcare supplier ParagonCare has grown its profit and revenue in the first half of the financial year and updated the market on its “transformational” merger with fellow distribution company CH2 ParagonCare reported half year revenue of $1.85bn for the first half of 2025, 13% higher than the same period last year, it told the Australian